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Temporary axillobifemoral bypass during
fenestrated aortic aneurysm repair
Jason Constantinou, FRCS, Argyrios Giannopoulos, MD, Jane Cross, FRCS,
Luke Morgan-Rowe, MBBS, Obiekezie Agu, FRCS, and Krassi Ivancev, MD, PhD, London, United Kingdom
Objective: Fenestrated endovascular aortic aneurysm repair (f-EVAR) of juxtarenal aneurysms requiring cannulation of
the superior mesenteric artery and renal arteries is technically challenging, has a long operating time, and requires bilateral
large-caliber sheath insertion into the femoral arteries. Consequently, the risk of lower limb ischemia and subsequent
reperfusion injury is increased. We describe the use of an adjunct temporary axillobifemoral bypass graft (TABFBG) for
f-EVAR and propose that it be used as a strategy to avoid ischemia–reperfusion injury in patients anticipated as being at
increased risk.
Methods: Consecutive patients from a tertiary referral center undergoing f-EVAR, between October 2008 and August
2011, were retrospectively analyzed. Patients with lower limb arterial occlusive disease and those with difficult anatomy
had an adjunct TABFBG.
Results: All patients presenting with a juxtarenal aortic aneurysm were treated endovascularly, regardless of aneurysm
anatomy and technical difficulties. There were 37 patients without TABFBG (group 1) and 27 with TABFBG (group 2).
No patients required open conversion. Sex and age were not significantly different between the groups. The median
ankle-brachial pressure index was significantly higher in group 1 (P .0001). The groups had similar median blood loss,
percentage of target vessel cannulation, and median stay in the intensive therapy unit. Morbidities were similar in both
groups. There were no significant differences in cardiac, renal, or respiratory complications between the groups. The
30-day mortality was 10.8% (n  4) in group 1 and 0% in group 2 (P  .046).
Conclusions: Our series has demonstrated a significant reduction in mortality (10.8% absolute risk reduction) and no
increase in morbidity with the use of a TABFBG for fenestrated grafts. This is likely a result of the reduction in ischemia
and ischemia–reperfusion injury in these patients. We therefore recommend the use of TABFBG in patients with proximal
severe stenotic or occlusive disease and those in whom an operative time of >4 hours is predicted (typically those for
whom three or more target fenestrations is planned). (J Vasc Surg 2012;56:1544-8.)
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jAdvances in endovascular techniques have led to the
emergence of fenestrated endovascular aortic aneurysm
repair (f-EVAR) for juxtarenal aneurysms. Evidence for
their use is currently limited to case series only1-5; however,
early results are encouraging, with a significant reduction in
30-day mortality compared with open repair.6
Insertion of fenestrated endografts and target vessel
cannulation is technically challenging and requires many
more procedural steps than standard EVAR. There is also a
steep learning curve associated with this procedure. Oper-
ation time may subsequently be much longer than for
standard EVAR. Moreover, as the number of target vessels
increases, so does the complexity of the procedure and,
consequently, the duration of the operation.7
F-EVAR requires the simultaneous insertion of bilat-
eral large-caliber femoral sheaths. These may occlude the
common femoral and iliac systems, particularly in patients
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1544ith concurrent stenotic disease. The risk of lower limb
schemia is therefore high. This, combined with a long
peration time, may initiate a reperfusion injury. Conse-
uences of these include hyperkalemia, renal failure, com-
artment syndrome, acute lung injury, and multiorgan
ailure (MOF) as a result of the systemic inflammatory
esponse syndrome.
We hypothesize that the more complex the procedure,
he greater the risk that a reperfusion injury will develop
nd that this may be reduced by the use of a temporary
xillobifemoral bypass graft (TABFBG). The aim of this
tudy was to determine the outcome of the use of an
djunct TABFG with f-EVAR.
ETHODS
This is a retrospective observational study of consecu-
ive patients undergoing elective f-EVAR at a tertiary refer-
al center from October 2008 to August 2011. All patients
resenting with a juxtarenal aortic aneurysm were
reated endovascularly, regardless of aneurysm anatomy
nd technical difficulties. Patients with lower limb prox-
mal stenotic (70%) and occlusive disease (confirmed
y preoperative arterial duplex imaging and an ankle-
rachial pressure index [ABPI] 0.9), or those with com-
lex anatomy (eg, target vessel disease or tortuosity) such
hat a long procedure (4 hours) was anticipated, as
udged by the senior physician in the unit (K.I.), underwent
n adjunct TABFBG.
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Volume 56, Number 6 Constantinou et al 1545Patients were divided into two groups. Group 1 consisted
of 37 patients who did not undergo a TABFBG. Group 2
consisted of 27 patients who underwent a TABFBG. Pri-
mary outcome was patient death. Secondary outcome was
patient morbidity.
Statistical analysis. Nonparametric continuous vari-
ables are described using medians and interquartile ranges
and were compared using a Mann-Whitney test. Categoric
variables are described using numbers and percentages and
were compared using 2 or Fisher exact tests. P values.05
were considered to be statistically significant.
Procedure details. General anesthesia was used in all
patients. In patients with pre-existing renal impairment,
preoperative intravenous hydration was routinely used. Pa-
tients were fully heparinized during the procedure.
The TABFBG was performed at the start of the proce-
dure. An 8-mmDacron graft was anastomosed end-to-side
proximally to the right axillary artery just below the clavicle
and passed extracorporeally to anastomose end-to-side to
the distal common femoral arteries after a femoral cut-
down. Subsequent cannulation of the common femoral
arteries and graft introduction (using 20F sheaths) was
performed just proximal to the anastomoses.
The axillary segment of the Dacron graft was used as a
proximal conduit allowing antegrade catheterization and
the introduction of a “through-and-through” wire as an
adjunct device. Standard cannulation of the fenestrations
and graft deployment was performed.8,9 When successful
aneurysm exclusion was confirmed by completion angiog-
raphy, the temporary bypass was amputated, and a small
remaining cuff of Dacron at each anastomosis was used as a
patch for closure.
Follow-up. Patients had routine postoperative follow-up
consisting of clinical examination and computed tomog-
raphy (CT) angiogram at 1 and 6 months, and yearly
thereafter. Renal function was monitored closely, and
patients with peripheral vascular disease were treated
Table I. Patient demographics
Variablesa Group 1 (n
Male 81.1
Age, years 74.9 (56
Preoperative morbidity
Diabetes 25.0
Hypertension 68.8
Current smoker 18.8
Cardiac history 37.5
ABPI 1.0265 (0.7
ASA classification
2 24.3
3 62.2
4 13.5
COPD 31.3
Chronic kidney diseaseb 31.3
ABPI, Ankle-brachial pressure index; ASA, American Society of Anesthesio
aCategoric data are presented as percentage and continuous data as median
bAssessed as estimated glomerular filtration rate of 60 mL/min/1.73 m3accordingly. dESULTS
During this period, 64 patients with juxtarenal aneu-
ysms underwent elective f-EVAR using custom-made fe-
estrated endografts (Cook Medical, Perth, WA, Austra-
ia). Patient demographics are presented in Table I. The
wo groups did not differ significantly in sex and age.
omorbidities were similar between each group, with the
xception of significantly higher pre-existing hypertension
n group 2. The median ABPI was significantly higher in
roup 1 than in group 2.
Procedure. No procedures required conversion to
pen repair. The total number of target vessels is reported
n Table II. Target vessels were reinforced with covered
trium stents (Atrium Medical, Hudson, NH). Two pa-
ients in each group had an accessory renal artery that
equired fenestration (as determined by preoperative radio-
sotope renography and CT angiography assessment). One
atient from group 1 and two from group 2 had a nonfunc-
ioning kidney that did not require a fenestration. Al-
hough themedian procedural time was longer for group 2,
his was not statistically significant. Only one unplanned
dditional intraoperative procedure was required, consist-
ng of the use of a covered stent after a rupture of a renal
rtery.
Morbidity and mortality. The 30-day mortality was
0.8% (n  4) in group 1 and 0% in group 2. In the first
atient, ischemic legs were noted at the end of the opera-
ion and a reperfusion injury developed that required fas-
iotomies and hemofiltration. He went on to developMOF
nd had a fatal myocardial infarction on day 3 after the
peration.
The second patient was noted to have ischemic legs at
he end of the operation, which slowly improved and did
ot require further intervention. However, he went on to
evelop renal and respiratory failure, and on cessation of
edation, was found to have had an intracerebral event. He
) Group 2 (n  27) P
85.2 .23
74.8 (60-86) .16
16.6 .54
100 .02
16.7 .87
66.7 .08
4) 0.866 (0.46-1.12) .0001
7.4 .55
77.8 .12
14.8 .31
22.2 .53
27.8 .19
; COPD, chronic obstructive pulmonary disease.
e). 37
-86)
1-1.2
logistsied of MOF on day 11 after the operation.
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December 20121546 Constantinou et alThe third patient had an intraoperative complication of
a ruptured left renal artery that required a covered stent.
She lost 450 mL of blood during the procedure and was
hypothermic on arrival in the intensive treatment unit. An
ischemic leg was noted on day 1 after the operation and
required an emergency femoropopliteal bypass and fas-
ciotomies. After this, she became coagulopathic and went
on to develop MOF, with ischemic colitis and respiratory
failure. She died 18 days later. The procedural times for the
three patients who developed leg symptoms were 450, 660,
and 520 minutes, respectively.
Finally, another patient died after infection of his stent
graft. He had previously been treated for a mycotic popli-
teal aneurysm and subsequently developed an aortic aneu-
rysm that was stented, since he was not a candidate for open
repair. The stent became infected soon after, leading to a
loss of proximal seal and aneurysm rupture. He died 28
days after the operation.
Morbidities were similar in both groups (Fig). There
were no significant differences in cardiac and respiratory
complications. Troponin-positive cardiac events occurred
in four patients in group 1 and three in group 2, whereas
chest infection occurred in six patients in group 1 and four
in group 2. No tracheostomies were required. Four patients
in group 1 and three in group 2 required temporary hemo-
filtration. Four groin hematomas occurred in group 1. Two
Table II. Procedural data
Variablea Group 1 (n 
Procedural time, min 294 (210-66
Blood loss, mL 1205 (200-50
Target vessels
Total number 86
Cannulation 100
Length of stay, days
Intensive therapy unit 5 (1-35)
Hospital 11 (2-54)
30-day mortality 10.8
aContinuous data are presented as median (range) and categoric data as per
Fig. Postoperative complications are shown for patients without
the temporary axillobifemoral bypass graft (TABFBG) (Group 1)
and those with the graft (Group 2).patients required an evacuation and the other two were lanaged conservatively. In group 2, one patient had a
roin infection that required negative pressure wound ther-
py dressing and antibiotics. In addition, two groin hema-
omas were treated conservatively.
ISCUSSION
F-EVAR for juxtarenal aneurysms is a complex pro-
edure with a significantly higher morbidity and mortal-
ty than standard EVAR. Reperfusion injury is a consid-
rable risk in these patients, and we have demonstrated that
he mortality from this may be reduced by the use of a
ABFBG.
In our series, a 20F or 22F sheath was introduced to
he ipsilateral side, and a 20F or 24F sheath was placed in
he contralateral femoral artery. This was necessary to
llow access for the small sheaths required for target
essel cannulation. The presence of large sheaths in both
emoral arteries, combined with a prolonged operative
ime and peripheral vascular disease, is likely to lead to
ower limb ischemia and the subsequent risk of reperfu-
ion injury. Lower limb lactate is reported to be signifi-
antly higher after EVAR than after open abdominal aortic
neurysm repair and remains elevated for at least 48 hours
ostoperatively.10
Although the issue of the rate of incidence of reperfu-
ion injury in patients with chronic limb ischemia vs those
ithout is debatable, we argue that patients without steno-
es of the common femoral or iliac arteries are less likely to
uffer complete occlusion of these vessels by the placement
f large sheaths.
Ischemic legs at the end of the procedure were discov-
red in two patients in group 1 after removal of the surgical
terile drapes. As a result of these complications, the use of
ransparent surgical sterile drapes for the feet was imple-
ented so that intraoperative leg ischemia could be more
losely monitored.
MOF developed in three of the four patients who died.
OF was thought to be directly related to a reperfusion
njury in two of the patients. As a result of these deaths, our
olicy regarding adjunct TABFG was implemented. No
atients who underwent this adjunct procedure developed
ostoperative reperfusion syndrome.
In our series, although the median procedure time was
Group 2 (n  27) P
319 (240-660) .12
1919 (240-4000) .53
75 .16
97.3 .42
6 (1-38) .47
11.5 (4-100) .52
0 .046
e or as indicated.37)
0)
00)onger for group 2, this was not statistically significant. The
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Volume 56, Number 6 Constantinou et al 1547TABFBG served as an additional access site, allowing ante-
grade catheterization of the target vessels before stent graft
deployment. These catheters were left in situ, thus marking
the position of the target vessels, making orientation of the
stent graft easier, and potentially shortening the procedure
time. Moreover, it allowed the option of antegrade target
vessel cannulation in patients where retrograde cannulation
proved difficult.
In some complex cases, multiple wires and catheters
from the axillary artery are necessary for the completion of
the procedure. Puncture of the Dacron graft at the site of
axillary anastomosis is a simple and safe procedure. Con-
versely, multiple puncture sites at the axillary artery may be
dangerous, given the fragility of this vessel. No neurologic,
cardiac, or ischemic complications have occurred in our
series as a consequence of the TABFBG. No associated
hematomas, wound infections, or local vascular complica-
tions occurred in relation to the axillary access.
The quantity of contrast used for each case was not
accurately recorded because carbon dioxide as a contrast
medium was introduced midway during this case series.
The TABFBG allows carbon dioxide to be delivered
straight into the ostium of renal arteries that are difficult to
catheterize. This facilitates catheterization without using
iodinated contrast.
Tortuous iliac arteries and severe neck angulation are
considered to be relative contraindications to f-EVAR.11 In
addition, patients with migrated endografts after previous
EVAR are technically challenging to treat. Axillary access,
facilitated by the TABFBG, enables the use of a through-
and-through “buddy wire” technique. This can then be
used to straighten a tortuous aorta or iliac arteries, thereby
aiding the procedure.
TABFBG has previously been described as an adjunc-
tive procedure to open aortic aneurysm repair and has been
shown to reduce left ventricular afterload.12-16 Aortic
cross-clamping increases mean aortic pressure and heart
rate, increasing the metabolic requirements of the heart
and, subsequently, increasing the risk of cardiac ischemia.
Despite a lack of data regarding the hemodynamic effect of
large sheaths in the iliac arteries, it is possible that the
TABFBG reduces cardiac afterload during f-EVAR.
Our unit previously published this technique after the
first two cases.7 We do not routinely use a TABFBG for
patients with favorable anatomy requiring straightforward
double fenestrations because this is a shorter, simpler pro-
cedure and the risk of reperfusion injury is therefore much
less. Similarly, we do not use it for branched devices be-
cause the iliofemoral access is occluded for a relatively short
period. The deployment of the branched graft is swiftly
followed by closure of the femoral access, with restoration
of flow. The branches are then cannulated, and bridging
stents are placed antegrade through brachial or axillary
access. The use of TABFG does come with potential com-
plications, including blood loss, vascular damage, and in-
fection, as highlighted by our patient in group 2 who
developed a groin infection postoperatively.The use of a TABFBG is an additional cost to the proce-
ure; however, this does not significantly affect the overall
ost of the operation. The savings made by the avoidance of
omplications, in our view, more than compensates for the
dditional costs. At the end of the operation, the temporary
raft is amputated, leaving a small cuff to aid closure of the
essel, avoiding stenosis. No cuff-related sepsis occurred in
his series.
ONCLUSIONS
F-EVAR is technically challenging. The procedure is
ften long and potentially involves occluding the arterial
upply to the legs. This, combined with concomitant pe-
ipheral vascular disease, likely increases the risk of intraop-
rative limb ischemia and subsequent postoperative reper-
usion syndrome. The use of an adjunct TABFBG decreases
his risk and may reduce mortality without contributing to
verall morbidity. We therefore recommend the use of
ABFG in patients with proximal severe stenotic or occlu-
ive disease, or both, and those in whom an operative time
f4 hours is predicted (typically those for whom three or
ore target fenestrations is planned).
UTHOR CONTRIBUTIONS
onception and design: KI, JC
nalysis and interpretation: JaCr, AG
ata collection: JC, AG
riting the article: JC, AG
ritical revision of the article: OA, LMR, KI
inal approval of the article: KI
tatistical analysis: JC, JaCr
btained funding: Not applicable
verall responsibility: KI
C and AG are joint first authors and contributed equally to
this work.
EFERENCES
1. Muhs BE, Verhoeven EL, Zeebregts CJ, Tielliu IF, Prins TR, Verhagen
HJ, et al. Mid-term results of endovascular aneurysm repair with
branched and fenestrated endografts. J Vasc Surg 2006;44:9-15.
2. Anderson JL, Adam DJ, Berce M, Hartley DE. Repair of thoracoab-
dominal aortic aneurysms with fenestrated and branched endovascular
stent grafts. J Vasc Surg 2005;42:600-7.
3. Verhoeven EL, Prins TR, Tielliu IF, van den Dungen JJ, Zeebregts CJ,
Hulsebos RG, et al. Treatment of short-necked infrarenal aortic aneu-
rysms with fenestrated stent-grafts: short-term results. Eur J Vasc En-
dovasc Surg 2004;27:477-83.
4. O’Neill S, Greenberg RK, Haddad F, Resch T, Sereika J, Katz E. A
prospective analysis of fenestrated endovascular grafting: intermediate-
term outcomes. Eur J Vasc Endovasc Surg 2006;32:115-23.
5. Kristmundsson T, Sonesson B, Malina M, Björses K, Dias N, Resch T.
Fenestrated endovascular repair for juxtarenal aortic pathology. J Vasc
Surg 2009;49:568-74; discussion: 74-5.
6. Nordon IM, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM.
Modern treatment of juxtarenal abdominal aortic aneurysms with fenes-
trated endografting and open repair–a systematic review. Eur J Vasc
Endovasc Surg 2009;38:35-41.
7. Manning BJ, Agu O, Richards T, Ivancev K, Harris PL. Temporary
axillobifemoral bypass as an adjunct to endovascular aneurysm repair
using fenestrated stent grafts. J Vasc Surg 2011;53:867-9.
11
1
1
JOURNAL OF VASCULAR SURGERY
December 20121548 Constantinou et al8. Greenberg RK, Haulon S, O’Neill S, Lyden S, Ouriel K. Primary
endovascular repair of juxtarenal aneurysms with fenestrated endovas-
cular grafting. Eur J Vasc Endovasc Surg 2004;27:484-91.
9. Moore R, Hinojosa CA, O’Neill S, Mastracci TM, Cinà CS. Fenestrated
endovascular grafts for juxtarenal aortic aneurysms: a step by step
technical approach. Catheter Cardiovasc Interv 2007;69:554-71.
10. Jonsson T, Larzon T, Jansson K, Arfvidsson B, Norgren L. Limb
ischemia after EVAR: an effect of the obstructing introducer? J Endo-
vasc Ther 2008;15:695-701.
11. Greenberg RK, Haulon S, Lyden SP, Srivastava SD, Turc A, Eagleton
MJ, et al. Endovascular management of juxtarenal aneurysms with
fenestrated endovascular grafting. J Vasc Surg 2004;39:279-87.
12. Neglén P, Eklöf B, Thomson D. Temporary incomplete ischemia of the
legs induced by aortic clamping in man. Metabolic and hemodynamic
effects of temporary extracorporeal by-pass. Scand J Thorac Cardiovasc
Surg 1983;17:289-98. S3. Comerota AJ, White JV. Reducing morbidity of thoracoabdominal
aneurysm repair by preliminary axillofemoral bypass. Am J Surg 1995;
170:218-22.
4. Lossing AG, Hatswell EM. Temporary axillofemoral bypass: its use in
high risk cardiac patients requiring urgent abdominal aneurysm repair.
Can J Cardiol 1996;12:467-8.
5. Kanemitsu S, Shimono T, Onoda K, Shimpo H. Temporary axillo-
femoral bypass for abdominal aortic aneurysm repair in high risk pa-
tients. Ann Thorac Cardiovasc Surg 2006;12:71-3.
6. Knott AW, Kalra M, Duncan AA, Reed NR, Bower TC, Hoskin TL, et
al. Open repair of juxtarenal aortic aneurysms (JAA) remains a safe
option in the era of fenestrated endografts. J Vasc Surg 2008;47:695-
701.ubmitted Oct 21, 2011; accepted May 9, 2012.
